These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24107621)

  • 1. Neuroinflammation and β amyloid deposition in Alzheimer's disease: in vivo quantification with molecular imaging.
    Hommet C; Mondon K; Camus V; Ribeiro MJ; Beaufils E; Arlicot N; Corcia P; Paccalin M; Minier F; Gosselin T; Page G; Guilloteau D; Chalon S
    Dement Geriatr Cogn Disord; 2014; 37(1-2):1-18. PubMed ID: 24107621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Nordberg A
    Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
    Rodriguez-Vieitez E; Kumar A; Malarte ML; Ioannou K; Rocha FM; Chiotis K
    Methods Mol Biol; 2024; 2785():195-218. PubMed ID: 38427196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease.
    López-Picón FR; Snellman A; Eskola O; Helin S; Solin O; Haaparanta-Solin M; Rinne JO
    J Nucl Med; 2018 Mar; 59(3):509-515. PubMed ID: 28986511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease.
    Janssen B; Mach RH
    Prog Mol Biol Transl Sci; 2019; 165():371-399. PubMed ID: 31481170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Imaging of Neuroinflammation in Alzheimer's Disease.
    Zhou R; Ji B; Kong Y; Qin L; Ren W; Guan Y; Ni R
    Front Immunol; 2021; 12():739130. PubMed ID: 34603323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular imaging of beta-amyloid plaques in the brain].
    Ono M
    Brain Nerve; 2007 Mar; 59(3):233-40. PubMed ID: 17370649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Alzheimer's disease.
    Zhang M; Qian XH; Hu J; Zhang Y; Lin X; Hai W; Shi K; Jiang X; Li Y; Tang HD; Li B
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):455-467. PubMed ID: 37801139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study.
    Parbo P; Ismail R; Sommerauer M; Stokholm MG; Hansen AK; Hansen KV; Amidi A; Schaldemose JL; Gottrup H; Brændgaard H; Eskildsen SF; Borghammer P; Hinz R; Aanerud J; Brooks DJ
    Neurobiol Dis; 2018 Sep; 117():211-216. PubMed ID: 29902557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
    Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A
    J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease.
    Higuchi M
    Curr Alzheimer Res; 2009 Apr; 6(2):137-43. PubMed ID: 19355848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Fan Z; Okello AA; Brooks DJ; Edison P
    Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain amyloid imaging.
    Rowe CC; Villemagne VL
    J Nucl Med; 2011 Nov; 52(11):1733-40. PubMed ID: 21917849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
    Mosconi L; Rinne JO; Tsui WH; Berti V; Li Y; Wang H; Murray J; Scheinin N; Någren K; Williams S; Glodzik L; De Santi S; Vallabhajosula S; de Leon MJ
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5949-54. PubMed ID: 20231448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
    Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
    Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo type 1 cannabinoid receptor availability in Alzheimer's disease.
    Ahmad R; Goffin K; Van den Stock J; De Winter FL; Cleeren E; Bormans G; Tournoy J; Persoons P; Van Laere K; Vandenbulcke M
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):242-50. PubMed ID: 24189376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.